In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence

Maximilian Balmus, Sheng‐Ya Wang, Edward W. G. Ashton, Rosie K. Barrows, Molly Monks, Yuzhang Ge, Arthur Lefebvre, Steven A. Niederer

Open source

DOI
10.1002/cpt.70492
Published
2026-09-27
Container
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70492,
  title = {In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence},
  author = {Maximilian Balmus and Sheng‐Ya Wang and Edward W. G. Ashton and Rosie K. Barrows and Molly Monks and Yuzhang Ge and Arthur Lefebvre and Steven A. Niederer},
  year = {2026},
  journal = {Clinical Pharmacology \& Therapeutics},
  doi = {10.1002/cpt.70492},
  url = {https://doi.org/10.1002/cpt.70492}
}

RIS

TY  - JOUR
TI  - In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence
AU  - Maximilian Balmus
AU  - Sheng‐Ya Wang
AU  - Edward W. G. Ashton
AU  - Rosie K. Barrows
AU  - Molly Monks
AU  - Yuzhang Ge
AU  - Arthur Lefebvre
AU  - Steven A. Niederer
PY  - 2026
JO  - Clinical Pharmacology & Therapeutics
DO  - 10.1002/cpt.70492
UR  - https://doi.org/10.1002/cpt.70492
ER  - 

APA

Balmus, M., Wang, S., Ashton, E. W. G., Barrows, R. K., Monks, M., Ge, Y., Lefebvre, A., & Niederer, S. A. (2026). In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70492

Source records